We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05318573
Brief Title: A Study to Evaluate Safety, Efficacy of FF-10832 in Combination With Pembrolizumab in Solid Tumors

First Submitted : March 29, 2022
First Submitted that Met QC Criteria : April 7, 2022
First Posted : April 8, 2022

Last Update Submitted that Met QC Criteria : October 19, 2022
Last Update Posted : October 20, 2022